Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Florham Park, New Jersey
- Most recent report
- 8-K, filed Sep 29, 2026
- Incorporated
- Delaware
- Filings on record
- 489 filings
- On EDGAR
- CIK 1783183
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 31
News 8 of 99
Prospectuses and Registrations 8 of 20
- S-8 Registration statement for an employee plan Mar 27, 2026
- 424B5 Prospectus supplement for an offering Jan 8, 2026
- 424B5 Prospectus supplement for an offering Jan 7, 2026
- S-3ASR Automatic shelf registration Jan 7, 2026
- S-8 Registration statement for an employee plan Apr 3, 2025
- S-8 Registration statement for an employee plan Mar 6, 2025
- 424B5 Prospectus supplement for an offering Aug 19, 2024
- FWP Free writing prospectus Aug 19, 2024
Proxies 8 of 16
- DEFA14A Extra proxy material Apr 7, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 7, 2026
- DEFA14A Extra proxy material Apr 23, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 23, 2025
- DEFA14A Extra proxy material Apr 12, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 12, 2024
- DEFA14A Extra proxy material Apr 13, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 13, 2023
Ownership 8 of 290
- 4 Insider reported a trade Sep 8, 2026
- SCHEDULE 13G Large holder reported a passive stake Jul 29, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jul 20, 2026
- 4 Insider reported a trade Jul 16, 2026
- 4 Insider reported a trade May 27, 2026
- 4 Insider reported a trade May 21, 2026
- 4 Insider reported a trade May 21, 2026
- 4 Insider reported a trade May 21, 2026
Other 8 of 33
- ARS Annual report sent to shareholders Apr 7, 2026
- ARS Annual report sent to shareholders Apr 23, 2025
- UPLOAD Comment letter from SEC staff Jun 25, 2024
- CORRESP Reply to SEC staff Jun 14, 2024
- UPLOAD Comment letter from SEC staff Jun 6, 2024
- ARS Annual report sent to shareholders Apr 12, 2024
- EFFECT Notice that a registration became effective Nov 17, 2023
- CORRESP Reply to SEC staff Nov 15, 2023
Everything here comes from Phathom Pharmaceuticals, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.